{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:08:54Z","timestamp":1777964934775,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.cgh.2016.07.016","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T09:09:59Z","timestamp":1469524199000},"page":"266-272.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Terlipressin Improves Renal Function and Reverses Hepatorenal\u00a0Syndrome in Patients With Systemic Inflammatory\u00a0Response\u00a0Syndrome"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9263-8869","authenticated-orcid":false,"given":"Florence","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen Chris","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas D.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun J.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmohan S.","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Escalante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khurram","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2016.07.016_bib1","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.cgh.2016.07.016_bib2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jhep.2009.04.017","article-title":"The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome","volume":"51","author":"Cazzaniga","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.07.016_bib3","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/hep.21920","article-title":"Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure","volume":"46","author":"Thabut","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.07.016_bib4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0168-8278(00)00013-1","article-title":"Bacterial translocation of enteric organisms in patients with cirrhosis","volume":"34","author":"Cirera","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.07.016_bib5","doi-asserted-by":"crossref","first-page":"e0120642","DOI":"10.1371\/journal.pone.0120642","article-title":"Ascites bacterial burden and immune cell profile are associated with poor clinical outcomes in the absence of overt infection","volume":"10","author":"Fagan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2016.07.016_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jhep.2007.08.012","article-title":"Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin","volume":"48","author":"Gonzalez-Navajas","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.07.016_bib7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1478-3231.2003.00870.x","article-title":"Coagulation disorders in patients with cirrhosis and severe sepsis","volume":"23","author":"Plessier","year":"2003","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2016.07.016_bib8","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1097\/01.CCM.0000138558.16257.3F","article-title":"Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock","volume":"32","author":"Sakr","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cgh.2016.07.016_bib9","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.27779","article-title":"Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis","volume":"62","author":"Michelena","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.07.016_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2016.07.016_bib11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nrgastro.2012.96","article-title":"Recent advances in our understanding of hepatorenal syndrome","volume":"9","author":"Wong","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2016.07.016_bib12","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2016.07.016_bib13","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.07.016_bib14","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Martin-Llahi","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.07.016_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ki.2014.338","article-title":"Renal dysfunction in cirrhosis is not just a vasomotor nephropathy","volume":"87","author":"Adebayo","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.cgh.2016.07.016_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/SHK.0000000000000052","article-title":"A\u00a0unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury","volume":"41","author":"Gomez","year":"2014","journal-title":"Shock"},{"key":"10.1016\/j.cgh.2016.07.016_bib17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/lt.24049","article-title":"Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation","volume":"21","author":"Wong","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cgh.2016.07.016_bib18","first-page":"39","article-title":"A\u00a0randomized, placebo-controlled, double-blind study to confirm the reversal of hepatorenal syndrome type 1 with terlipressin: the REVERSE trial design","volume":"4","author":"Boyer","year":"2012","journal-title":"Open Access J Clin Trials"},{"key":"10.1016\/j.cgh.2016.07.016_bib19","series-title":"Clinical methods: the history, physical, and laboratory examinations","first-page":"888","article-title":"Serum total carbon dioxide","author":"Centor","year":"1990"},{"key":"10.1016\/j.cgh.2016.07.016_bib20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1478-3231.2004.0951.x","article-title":"Implication of inflammation-related cytokines in the natural history of liver cirrhosis","volume":"24","author":"Giron-Gonzalez","year":"2004","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2016.07.016_bib21","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.07.016_bib22","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2013.12.032","article-title":"Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis","volume":"60","author":"Rodriguez","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.07.016_bib23","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2016.07.016_bib24","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1365-2044.2004.03877.x","article-title":"Vasopressin and terlipressin: pharmacology and its clinical relevance","volume":"59","author":"Kam","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1016\/j.cgh.2016.07.016_bib25","doi-asserted-by":"crossref","first-page":"e29693","DOI":"10.1371\/journal.pone.0029693","article-title":"The effects of terlipressin on regional hemodynamics and kidney function in experimental hyperdynamic sepsis","volume":"7","author":"Ishikawa","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2016.07.016_bib26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0168-8278(97)80428-X","article-title":"Time profile of the haemodynamic effects of terlipressin in portal hypertension","volume":"26","author":"Escorsell","year":"1997","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.07.016_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","article-title":"Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics","volume":"55","author":"Boyer","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.07.016_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"51","author":"Nazar","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2016.07.016_bib29","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1440-1746.2009.05873.x","article-title":"Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis","volume":"24","author":"Narahara","year":"2009","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2016.07.016_bib30","first-page":"161","article-title":"Cytokines in the systemic inflammatory response syndrome: a review","volume":"2","author":"Jaffer","year":"2010","journal-title":"HSR Proc Intensive Care Cardiovasc Anesth"},{"key":"10.1016\/j.cgh.2016.07.016_bib31","doi-asserted-by":"crossref","first-page":"16795","DOI":"10.3748\/wjg.v20.i45.16795","article-title":"Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis","volume":"20","author":"Giannelli","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.07.016_bib32","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2016.07.016_bib33","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1523\/JNEUROSCI.4922-03.2004","article-title":"Suppression of proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha in astrocytes by a V1 vasopressin receptor agonist: a cAMP response element-binding protein-dependent mechanism","volume":"24","author":"Zhao","year":"2004","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.cgh.2016.07.016_bib34","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/jhep.2002.36501","article-title":"Terlipressin inhibits in\u00a0vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis","volume":"36","author":"Moreau","year":"2002","journal-title":"Hepatology"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356516304372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356516304372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:21:46Z","timestamp":1761542506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356516304372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1542356516304372"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2016.07.016","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Terlipressin Improves Renal Function and Reverses Hepatorenal\u00a0Syndrome in Patients With Systemic Inflammatory\u00a0Response\u00a0Syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2016.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the AGA Institute","name":"copyright","label":"Copyright"}]}}